INNOVATE BIOPHARMACEUTICLS I's ticker is INNT and the CUSIP is 45782F105. A total of 31 filers reported holding INNOVATE BIOPHARMACEUTICLS I in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $1,000 | -50.0% | 2,322 | 0.0% | 0.00% | – |
| Q3 2019 | $2,000 | -50.0% | 2,322 | -25.1% | 0.00% | – |
| Q2 2019 | $4,000 | -60.0% | 3,102 | -44.4% | 0.00% | – |
| Q1 2019 | $10,000 | -16.7% | 5,577 | +2.9% | 0.00% | – |
| Q4 2018 | $12,000 | -65.7% | 5,422 | +6.7% | 0.00% | – |
| Q3 2018 | $35,000 | -43.5% | 5,080 | +92.0% | 0.00% | – |
| Q2 2018 | $62,000 | – | 2,646 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| IFP Advisors, Inc | 0 | $0 | 0.00% |